Lipid and hyperglycemia factors in first-ever penetrating artery infarction, a comparison between different subtypes

Shaoyang Sun1, Yanqiang Wang2, Yuge Wang3

  • 1Department of Neurology The Affiliated Hospital of Qingdao University Qingdao China.

Brain and Behavior
|June 23, 2017
PubMed

Insights

Branch atheromatous disease (BAD) and lipohyalinotic degeneration (LD) in penetrating artery infarction (PAI) differ. Elevated LDL-C is linked to BAD progression, while age and HbA1c correlate with pontine penetrating artery infarction.

Area of Science:

  • Neurology
  • Cardiovascular Research
  • Metabolic Disorders

Background:

  • Branch atheromatous disease (BAD) pathogenesis and progression are debated, especially compared to lipohyalinotic degeneration (LD).
  • Limited research exists on lipid indices and glycometabolism in BAD within first-ever penetrating artery infarction (PAI).

Purpose of the Study:

  • To investigate lipid profiles and glycometabolism in patients with PAI.
  • To differentiate factors contributing to BAD versus LD in PAI.
  • To explore associations between these factors and stroke progression.

Main Methods:

  • Retrospective analysis of acute stroke patients with PAI admitted within 3 days.
  • Utilized diffusion-weighted MRI, MRA, and/or CTA for diagnosis.
  • Defined progression as ≥2-point increase in NIH Stroke Scale score; statistically analyzed clinical data.

Main Results:

  • BAD diagnosed in 57% and LD in 43% of patients.
  • Higher LDL-C in BAD patients (p=.013), linked to early neurological deterioration (p=.045).
  • Lenticulostriate artery (LSA) infarction more common (75.1%) than pontine penetrating artery (PPA) infarction (24.9%); PPA more prevalent in BAD (34.5% vs 12.1%, p<.001).
  • PPA infarction associated with older age at onset and higher HbA1c in BAD/LD patients (p=.014, p=.036).

Conclusions:

  • Elevated LDL-C may contribute to intracranial BAD pathogenesis and progression.
  • LSA infarction is the most frequent PAI subtype.
  • Age at onset and HbA1c are associated with PPA infarction in first-ever PAI.
Abstract

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
487
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
815
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
488
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
366
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K